Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Labeling “Highlights” To Depend On Data In Relation To Clinical Setting

Jan 23 2006

• By The Pink Sheet

Related Content

Rx Label "Highlights" Under FDA Rule Could Yield Inconsistencies - Merck

Apr 16 2001

Indication, Warning Summaries In Labeling "Highlights" - FDA Rule

Jan 01 2001

Boxed Warnings To Be Considered For Drugs With Risk Unique To Class

Jan 23 2006

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window